In vivo CRISPR-Cas9 inhibition of hepatic LDH as treatment of primary hyperoxaluria
Autor: | Rebeca Martinez-Turrillas, Angel Martin-Mallo, Saray Rodriguez-Diaz, Natalia Zapata-Linares, Paula Rodriguez-Marquez, Patxi San Martin-Uriz, Amaia Vilas-Zornoza, María E. Calleja-Cervantes, Eduardo Salido, Felipe Prosper, Juan R. Rodriguez-Madoz |
---|---|
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | Molecular Therapy - Methods & Clinical Development. 25:137-146 |
ISSN: | 2329-0501 |
DOI: | 10.1016/j.omtm.2022.03.006 |
Databáze: | OpenAIRE |
Externí odkaz: |